Compare JetBlue Airways Corporation (JBLU) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JetBlue Airways Corporation vs BIO-TECHNE Corp — how do they compare? JetBlue Airways Corporation trades at $5.81 (market cap $2.19B), while BIO-TECHNE Corp trades at $72.13 (market cap $11.24B). The key difference: BIO-TECHNE Corp is far larger — about 5.1× JetBlue Airways Corporation's market cap, and BIO-TECHNE Corp pays a 0.44% dividend while JetBlue Airways Corporation pays none. Which is the better fit depends on your goals.
| JBLU | TECH | |
|---|---|---|
Market Cap | $2.19B | $11.24B |
Sector | Industrials | Health |
52-Week High | $6.46 | $72.29 |
52-Week Low | $4.03 | $43.31 |
Enterprise Value | $9.56B | $11.32B |
Dividend Yield | — | 0.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JetBlue (JBLU) trades at $5.855, up 3.81% today, with a bullish technical signal from moving averages but mixed earnings history including a recent Q2 2026 beat. The company shows negative profitability with a net income margin of -9.32% and ROE of -44.36%, while valuation ratios like P/S of 0.23 suggest potential undervaluation. Recent news highlights analyst downgrades and operational challenges from high fuel costs, alongside strategic initiatives like new fare structures and lounge awards.
Outlook remains cautious due to persistent losses and external pressures, but cost management and revenue growth initiatives offer recovery potential. Key risks include fuel price volatility and competitive intensity, while analyst consensus is neutral with a $5.18 price target slightly below current levels, indicating limited near-term upside amid ongoing fundamental headwinds.
TECH trades at $72.25, up 0.18% today, with a bullish technical signal and moving averages supporting an uptrend. The company reported Q4 2026 earnings of $0.52 per share, meeting estimates, while revenue beat expectations on strong research and diagnostics demand. Financials show a gross profit margin of 64.96%, but net income margin has declined to 9.05% in 2025 from 25.09% in 2023. Analyst consensus is evenly split between Buy and Hold, with a price target of $71.67.
The stock presents a mixed outlook: strong cash flow and institutional interest contrast with high valuation multiples and margin compression. Key risks include competitive pressures and execution challenges in maintaining profitability. Upside potential hinges on sustained revenue growth and margin recovery, but investors should weigh the elevated P/E of 103 against earnings stability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It carries over millions of customers with an average of more than 1,000 daily flights and served approximately 99 destinations in the United States, the Caribbean, and Latin America. The company currently operates Airbus A321, Airbus A320, and Embraer E190 aircraft types.
Read more on JBLU →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
